Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-in Patients in Ongoing Human Clinical Trial
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.